Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yehuda Handelsman

Showing results (41-50 of 157) with videos related to

Pageof 16
Sort By:
Diabetes, Obesity & Metabolism|April 27, 2010
Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidenceVivian A Fonseca, Yehuda Handelsman, Bart Staels
Annals of Internal Medicine|February 8, 2012
Effectiveness of primary care-relevant treatments for obesity in adultsAlan C Moses, Yehuda Handelsman, Daniel Einhorn
Metabolism: Clinical and Experimental|May 14, 2025
Use of finerenone in patients with chronic kidney disease at high risk of heart failureJohn P Hakim, Yehuda Handelsman, Trina Banerjee
Diabetes Care|September 22, 2017
Response to Comment on Bloomgarden et al. Is HbA<sub>1c</sub> <7% a Marker of Poor Performance in Individuals >65 Years Old? Diabetes Care 2017;40:526-528Zachary T Bloomgarden, Daniel Einhorn, Yehuda Handelsman
Diabetes Care|March 23, 2017
Is HbA<sub>1c</sub> <7% a Marker of Poor Performance in Individuals >65 Years Old?Zachary T Bloomgarden, Daniel Einhorn, Yehuda Handelsman
Vascular Health and Risk Management|October 29, 2020
Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future ProspectsDaniel A Duprez, Yehuda Handelsman, Michael Koren
Journal of Diabetes|January 3, 2019
Fournier's gangrene and sodium-glucose cotransporter 2 inhibitors: Is there a causal association?Zachary Bloomgarden, Daniel Einhorn, George Grunberger, et al.
Journal of the American College of Cardiology|September 9, 2017
Concomitant Diabetes and Atrial Fibrillation: No Sugarcoating the Bittersweet RealityZachary T Bloomgarden, Mikhail N Kosiborod, Yehuda Handelsman
Journal of Diabetes|January 31, 2017
Diabetes treatment over age 65: Is worse control really better?Zachary Bloomgarden, Christian Mende, Daniel Einhorn, et al.
Current Opinion in Clinical Nutrition and Metabolic Care|February 8, 2007
Hypoglycemia in the intensive care unitJeffrey I Mechanick, Yehuda Handelsman, Zachary T Bloomgarden
Pageof 16

Showing results (41-50 of 157) with videos related to

Sort By:
Pageof 16
Diabetes, Obesity & Metabolism|April 27, 2010
Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidenceVivian A Fonseca, Yehuda Handelsman, Bart Staels
Annals of Internal Medicine|February 8, 2012
Effectiveness of primary care-relevant treatments for obesity in adultsAlan C Moses, Yehuda Handelsman, Daniel Einhorn
Metabolism: Clinical and Experimental|May 14, 2025
Use of finerenone in patients with chronic kidney disease at high risk of heart failureJohn P Hakim, Yehuda Handelsman, Trina Banerjee
Diabetes Care|September 22, 2017
Response to Comment on Bloomgarden et al. Is HbA<sub>1c</sub> <7% a Marker of Poor Performance in Individuals >65 Years Old? Diabetes Care 2017;40:526-528Zachary T Bloomgarden, Daniel Einhorn, Yehuda Handelsman
Diabetes Care|March 23, 2017
Is HbA<sub>1c</sub> <7% a Marker of Poor Performance in Individuals >65 Years Old?Zachary T Bloomgarden, Daniel Einhorn, Yehuda Handelsman
Vascular Health and Risk Management|October 29, 2020
Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future ProspectsDaniel A Duprez, Yehuda Handelsman, Michael Koren
Journal of Diabetes|January 3, 2019
Fournier's gangrene and sodium-glucose cotransporter 2 inhibitors: Is there a causal association?Zachary Bloomgarden, Daniel Einhorn, George Grunberger, et al.
Journal of the American College of Cardiology|September 9, 2017
Concomitant Diabetes and Atrial Fibrillation: No Sugarcoating the Bittersweet RealityZachary T Bloomgarden, Mikhail N Kosiborod, Yehuda Handelsman
Journal of Diabetes|January 31, 2017
Diabetes treatment over age 65: Is worse control really better?Zachary Bloomgarden, Christian Mende, Daniel Einhorn, et al.
Current Opinion in Clinical Nutrition and Metabolic Care|February 8, 2007
Hypoglycemia in the intensive care unitJeffrey I Mechanick, Yehuda Handelsman, Zachary T Bloomgarden
Pageof 16